
A Medicine Company | Eli Lilly and Company
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Eli Lilly and Company - Wikipedia
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
Eli Lilly and Company (LLY) - Yahoo Finance
Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.
Available Medications - Lilly Cares
Frequently Asked Questions (FAQ) What if my medication is not listed or I don't qualify for Lilly Cares?
Find Your Career with Eli Lilly | Lilly Careers
Find your place at Lilly with Lilly Careers. For more than a century, we have united caring with discovery to make life better, join us today.
Prediction: 2026 Will Be the Year of Eli Lilly - The Motley Fool
4 days ago · Eli Lilly is tackling a high-growth market: weight loss. The company’s weight loss portfolio brought in $10 billion in the recent quarter. So, why has Lilly become a growth stock? The company ...
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other ...
Jan 15, 2026 · Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite assurances of swift reviews under the FDA's new …
Eli Lilly and Company (LLY) Market Cap & Net Worth
6 days ago · Current and historical market capitalization for Eli Lilly and Company (LLY) stock, including annual, quarterly and daily history with a chart and statistics.
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company ...
Eli Lilly and Company was established in May 1876 in Indianapolis, Indiana by Eli Lilly, a pharmaceutical chemist who served as a colonel in the Union Army during the U.S. Civil War.
Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn
Jan 8, 2026 · Eli Lilly has agreed to acquire autoimmune oral drug developer Ventyx Biosciences, representing the big pharma company’s latest push to diversify its pipeline beyond blockbuster …